Int J Stem Cells.  2016 Nov;9(2):221-229. 10.15283/ijsc16024.

Assessment of the Role of Noni (Morinda citrifolia) Juice for Inducing Osteoblast Differentiation in Isolated Rat Bone Marrow Derived Mesenchymal Stem Cells

Affiliations
  • 1Dental Sciences, Bharat University, Madha Dental College and Hospital, Dr.MGR Medical University, Chennai, Tamilnadu, India.
  • 2School of BioSciences and Technology, Vellore Institute of Technology, VIT University, Vellore, Tamilnadu, India. tamizhselvi.r@vit.ac.in

Abstract

BACKGROUND AND OBJECTIVES
Morinda citrifolia (Noni), an important traditional medicinal plant still used in patients with bone fractures or dislocation to promote connective tissue repair and to reduce inflammation. However, the effects of Noni on bone metabolism and whether it influences the osteogenic differentiation is yet to be clarified. In this study, we investigated the effect of Morinda citrifolia (Noni) juice on the proliferation rate of rat bone marrow derived mesenchymal stem cells (BMSC) and the osteoblastic differentiation as shown by alkaline phosphatase (ALP), Runt-related transcription factor 2 (Runx2) and osteocalcin (OCN) mRNA expression in vitro.
METHODS AND RESULTS
Treatment with 200 μg/ml Noni juice enhanced the proliferation rate of the BMSC and also upregulated the osteogenic differentiation marker genes ALP and OCN, and Runx2 measured by RTPCR. Consistent with these results collagen scaffolds implanted in vivo, which were loaded with BMSC pre-exposed to Noni, showed increased bone density measured by computed tomography and histological analysis revealed neo-angiogenesis for bone formation.
CONCLUSIONS
These results suggest that Noni stimulates osteoblastogenesis and can be used as adjuvant natural medicine for bone diseases such as osteoporosis.

Keyword

Bone marrow derived mesenchymal stem cells; Morinda citrifolia; Alkaline phosphatase; Runt-related transcription factor 2; Osteocalcin

MeSH Terms

Alkaline Phosphatase
Animals
Bone Density
Bone Diseases
Bone Marrow*
Collagen
Connective Tissue
Dislocations
Fractures, Bone
Humans
In Vitro Techniques
Inflammation
Mesenchymal Stromal Cells*
Metabolism
Morinda*
Osteoblasts*
Osteocalcin
Osteogenesis
Osteoporosis
Plants, Medicinal
Rats*
RNA, Messenger
Transcription Factors
Alkaline Phosphatase
Collagen
Osteocalcin
RNA, Messenger
Transcription Factors

Figure

  • Fig. 1 Rat BMSC where cultured with varying doses of Noni (50, 75, 100, 125, 150, 175, 200 and 250 μg/ml) for 24 h. Noni at a concentration of 200μg/ml significantly increased the proliferation of BMSC. MTT assay was performed to measure the cell proliferation as described in Materials and Methods. The data are mean±SD, n=6. *p<0.01 and #p<0.001 as compared with BMSC (BMSC-bone marrow derived mesenchymal stem cells).

  • Fig. 2 Effect of Noni (200 μg/ml) on rat bone marrow derived stem cells after 5 days and before inducing with osteogenesis media. Morphology of cells (A) without and with (B) Noni on the fifth day (40× objectives). (C) Transcriptional analysis for the expression of mesenchymal stem cell marker genes CD 44 and CD 90 generated from 5 independent experiments that were normalized with β actin. (D) Growth curve of rat BMSC through 6 days. At day 1, 2, 3, 4, 5, 6 first passage BMSCs in DMEM with or without noni were plated in each well of a 96-well plate; cell number was then evaluated at different times via Thiazolyl blue (MTT) staining. Noni at a concentration of 200 μg/ml showed a significant increase in BMSC proliferation from 2nd through 5th day. MTT results are reported as percentages (BMSC-bone marrow derived mesenchymal stem cells).

  • Fig. 3 Transcriptional analysis for the expression of osteogenic marker genes in bone marrow derived stem cells after 7 days of differentiation in the presence of Noni (200 μg/ml). (A) Semiquantitative RT-PCR detection of ALP, runx2 and OCN mRNA expression in cells treated with and without Noni. Sample loading was normalized with GAPDH internal control. (B) A significant increase in ALP, Runx2 and OCN was observed by real-time analysis. The data are mean±SD. Results of 3 to 5 experiments are shown. *p<0.01 when compared with BMSC (BMSC-bone marrow derived mesenchymal stem cells).

  • Fig. 4 Histological appearance of bone regeneration by implanting BMSC with Noni (200 μg/ml). Surgical specimens 6 weeks after implantation of (A) Type I collagen with BMSC shows normal bone healing with single harvesian system. (B) Type I collagen with BMSC and Noni, arrow showing neo-vascularization with additional blood vessels and increased bone density. (C) Histogram shown the new bone formation 6 weeks after implantation of type I collagen with BMSC and Noni (n=6). The data are mean±SD. *p<0.01 when compared with type I collagen and BMSC group (BMSC-bone marrow derived mesenchymal stem cells).


Reference

References

1. The United Nations (UN). 2012. Available from: http://www.un.org/en/. Accessed July 2012.
2. The World Health Organization (WHO). 2012. Available from: http://www.who.int/en/. Accessed July 2012.
3. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003; 81:646–656.
4. Scheven BA, Visser JW, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature. 1986; 321:79–81. DOI: 10.1038/321079a0. PMID: 3754620.
Article
5. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011; 13:27–38. DOI: 10.1038/nrm3254. PMID: 22189423.
Article
6. Deng S, West BJ, Palu ‘K, Jensen CJ. Determination and comparative analysis of major iridoids in different parts and cultivation sources of Morinda citrifolia. Phytochem Anal. 2011; 22:26–30. DOI: 10.1002/pca.1246.
Article
7. Paredes R, Arriagada G, Cruzat F, Olate J, Van Wijnen A, Lian J, Stein G, Stein J, Montecino M. The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J Steroid Biochem Mol Biol. 2004; 89–90:269–271. DOI: 10.1016/j.jsbmb.2004.03.076.
8. Johnsen SA, Subramaniam M, Ruesink TJ, Spelsberg TC. Opposing roles of osterix and TGF beta inducible early gene in osteoblast differentiation downstream of Cbfa1/Runx2. J Bone Miner Res. 2002; 17:1016–1019.
9. Marom R, Shur I, Solomon R, Benayahu D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol. 2005; 202:41–48. DOI: 10.1002/jcp.20109.
Article
10. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord. 2001; 2:81–94. DOI: 10.1023/A:1010011209064. PMID: 11704982.
11. Bushnell OA, Fukuda M, Makinodian T. The antibacterial properties of some plants found in Hawaii. Pac Sci. 1950; 4:167–183.
12. Pawlus AD, Su BN, Keller WJ, Kinghorn AD. An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni). J Nat Prod. 2005; 68:1720–1722. DOI: 10.1021/np050383k. PMID: 16378361.
Article
13. Akihisa T, Matsumoto K, Tokuda H, Yasukawa K, Seino K, Nakamoto K, Kuninaga H, Suzuki T, Kimura Y. Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni). J Nat Prod. 2007; 70:754–757. DOI: 10.1021/np068065o. PMID: 17480098.
Article
14. Alitheen NB, Manaf AA, Yeap SK, Shuhaimi M, Nordin L, Mashitoh AR. Immunomodulatory effects of damnacanthal isolated from roots of Morinda elliptica. Pharm Biol. 2010; 48:446–452. DOI: 10.3109/13880200903168031. PMID: 20645725.
Article
15. Gupta RK, Patel AK. Do the health claims made for Morinda citrifolia (Noni) harmonize with current scientific knowledge and evaluation of its biological effects. Asian Pac J Cancer Prev. 2013; 14:4495–4499. DOI: 10.7314/APJCP.2013.14.8.4495. PMID: 24083691.
Article
16. Wong YH, Abdul Kadir H. Induction of mitochondria-mediated apoptosis in Ca Ski human cervical cancer cells triggered by mollic acid arabinoside isolated from leea indica. Evid Based Complement Alternat Med. 2012; DOI: 10.1155/2012/684740.
17. Gupta RK, Banerjee A, Pathak S, Sharma C, Singh N. Induction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells. Asian Pac J Cancer Prev. 2013; 14:237–242. DOI: 10.7314/APJCP.2013.14.1.237. PMID: 23534730.
Article
18. West BJ, Deng S, Jensen CJ. Nutrient and phytochemical analyses of processed noni puree. Food Res Intern. 2011; 44:2295–2301. DOI: 10.1016/j.foodres.2010.09.038.
Article
19. Geiger F, Lorenz H, Xu W, Szalay K, Kasten P, Claes L, Augat P, Richter W. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone. 2007; 41:516–522. DOI: 10.1016/j.bone.2007.06.018. PMID: 17693148.
Article
20. Kasten P, Luginbühl R, van Griensven M, Barkhausen T, Krettek C, Bohner M, Bosch U. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials. 2003; 24:2593–2603. DOI: 10.1016/S0142-9612(03)00062-0. PMID: 12726713.
Article
21. Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM, Yadav DK, Mishra JS, Singh AB, Sanyal S, Goel A, Maurya R, Chattopadhyay N. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem. 2009; 108:388–399. DOI: 10.1002/jcb.22264. PMID: 19598169.
Article
22. Bramorski A, Cherem AR, Marmentini CP, Torresani J, Mezadri T, Costa AAS. Total polyphenol content and antioxidant activity of commercial Noni (Morinda citrifolia L.) juice and its components. Braz J Pharm Sci. 2010; 46:651–656. DOI: 10.1590/S1984-82502010000400006.
Article
23. Srivastava S, Bankar R, Roy P. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. Phytomedicine. 2013; 20:683–690. DOI: 10.1016/j.phymed.2013.03.001. PMID: 23570998.
Article
24. Deschaseaux F, Sensébé L, Heymann D. Mechanisms of bone repair and regeneration. Trends Mol Med. 2009; 15:417–429. DOI: 10.1016/j.molmed.2009.07.002. PMID: 19740701.
Article
25. Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995; 15:1858–1869. DOI: 10.1128/MCB.15.4.1858. PMID: 7891679. PMCID: 230411.
Article
26. Mohd Zin Z, Abdul Hamid A, Osman A, Saari N, Misran A. Isolation and identification of antioxidative compound from fruit of mengkudu (Morinda citrifolia L). Int J Food Prop. 2007; 10:363–373. DOI: 10.1080/10942910601052723.
Article
27. Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int. 2005; 16:2039–2045. DOI: 10.1007/s00198-005-1995-0. PMID: 16170444.
Article
28. Parenteau-Bareil R, Gauvin R, Berthod F. Collagen-based biomaterials for tissue engineering applications. Materials. 2010; 3:1863–1887. DOI: 10.3390/ma3031863.
Article
29. Rodrigues M, Turner O, Stolz D, Griffith LG, Wells A. Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transplant. 2012; 21:2171–2187. DOI: 10.3727/096368912X639035. PMID: 22526333. PMCID: 3876879.
Article
30. Dussossoy E, Brat P, Bony E, Boudard F, Poucheret P, Mertz C, Giaimis J, Michel A. Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). J Ethnopharmacol. 2011; 133:108–115. DOI: 10.1016/j.jep.2010.08.063.
Article
31. Serafini MR, Santos RC, Guimarães AG, Dos Santos JP, da Conceicão Santos AD, Alves IA, Gelain DP, de Lima Nogueira PC, Quintans-Júnior LJ, Bonjardim LR, de Souza Araújo AA. Morinda citrifolia Linn leaf extract possesses antioxidant activities and reduces nociceptive behavior and leukocyte migration. J Med Food. 2011; 14:1159–1166. DOI: 10.1089/jmf.2010.0254. PMID: 21548805.
Article
32. Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu AK, Anderson G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin. 2002; 23:1127–1141. PMID: 12466051.
33. Potterat O, Hamburger M. Morinda citrifolia (Noni) fruit--phytochemistry, pharmacology, safety. Planta Med. 2007; 73:191–199. DOI: 10.1055/s-2007-967115. PMID: 17286240.
Article
34. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, Xue A, Montag AG, Luu HH, Haydon RC, He TC. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008; 13:2001–2021. DOI: 10.2741/2819.
35. Wang MY, Lutfiyya MN, Weidenbacher-Hoper V, Anderson G, Su CX, West BJ. Antioxidant activity of noni juice in heavy smokers. Chem Cent J. 2009; 3:13–17. DOI: 10.1186/1752-153X-3-13. PMID: 19807926. PMCID: 2765950.
Article
Full Text Links
  • IJSC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr